Regor announced its 12-week single-dose Phase 2a trial results for RGT-075, a once-daily oral GLP-1RA, reporting 5% placebo-adjusted weight-loss with no plateau No treatment-related severe adverse events (AEs), with only 4% discontinuation rate due to AEs, same as placebo Enrollment…
Category: Uncategorized
PRINCETON, N.J., January 10, 2025 /3BL/ – Bristol Myers Squibb (NYSE: BMY) today announced that it has been named in the prestigious Dow Jones Sustainability Index (DJSI) for the second consecutive year. This recognition further validates the company’s impactful progress towards and prioritization of its environmental, social and governance (ESG) initiatives and aspirations.
The Dow Jones Sustainability Indices, including the Dow Jones Sustainability World Index (DJSI World), were launched in 1999 as the pioneering series of global sustainability benchmarks available in the market. The index family is comprised of global, regional and country benchmarks. DJSI North America includes the top 20 percent of the largest 600 companies in North America based on sustainability criteria.
As a leading biopharmaceutical company, Bristol Myers Squibb recognizes that its responsibility extends well beyond the discovery, development, and delivery of innovative medicines. BMS’ ESG strategy focuses on advancing patient health and fostering a high-performing, inclusive workforce, while expanding the boundaries of science and reducing environmental impact. They remain steadfast in their ongoing commitment to advancing health equity around the world, and the recent acknowledgement by the Dow Jones Sustainability Indices is a testament to the impact of the evolved Bristol Myers Squibb ESG strategy.
Learn more about BMS’ ESG strategy and progress in its 2023 ESG Report.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X, YouTube, Facebook and Instagram.
WARWICK, R.I., Jan. 10, 2025 /PRNewswire/ — Cruising has reached new heights of popularity, with newer, larger ships, with incredible amenities – redefining the travel experience. As more travelers book these unique vacations, understanding the nuances of cruise travel insurance has…
Sticking to your New Year’s Resolutions Just Got a Lot More Rewarding with SodaStream’s Tips for Sips Program PURCHASE, N.Y., Jan. 10, 2025 /PRNewswire/ — SodaStream®, the world’s leading sparkling water maker brand, is helping consumers to drink better in the new year, encouraging them…
Co-developers Charney Companies and Tavros Capital have opened the doors to their newest residential experience for modern living BROOKLYN, N.Y., Jan. 10, 2025 /PRNewswire/ — Leasing has launched at Union Channel, located at 240 Third Avenue, in Gowanus, Brooklyn; it is the first of four…
GLENDALE, Ariz., Jan. 10, 2025 /PRNewswire/ — Western Maricopa Education Center (West-MEC), a career technical education school district (CTED) serving students in the West Valley, recently broke ground on a $13.5 million expansion of its Northeast Campus, located at 1617 W. Williams Dr….
Special Event LANCASTER, Calif., Jan. 10, 2025 /PRNewswire/ — WHEN: Tuesday, January 14, 2025 at 1:30 p.m. WHAT: Through a community-led approach to policing, the Lancaster Police Department (LPD) is continuing to grow their efforts towards public safety in our City. In another…
Taxpayers can e-file their federal tax returns earlier than the official opening of the tax filing season at www.IRS.gov/FreeFile WASHINGTON, Jan. 10, 2025 /PRNewswire/ — Taxpayers can get a head start on preparing their tax returns as free federal tax preparation and e-filing software…
LAS VEGAS, Jan. 10, 2025 /PRNewswire/ — RingConn, a leading smart wearable brand, is proud to announce its participation in this year’s CES, showcasing two groundbreaking products on the international stage: the RingConn Gen 2, which successfully raised over $4 million on Kickstarter in…
SurVaxM is the first drug product to be produced in UI Pharmaceuticals new facility UI Pharmaceuticals is looking forward to supporting the need for larger clinical and commercial lots MimiVax is utilizing SurVaxM in a Randomized Phase 2b clinical trial of glioblastoma BUFFALO, N.Y., Jan….
